previous compound ID: 2752 next compound
InChIKey: YTNKWDJILNVLGX-UHFFFAOYSA-N
SMILES: CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "B Kus" "DY Thomas" "J Liao" "GW Carlile" "E Matthes" "D Rotin" "JW Hanrahan" "J Goepp" "R Robert"

chemical graph of compound 2752





CID is 71764
synonyms found at PubChem are:
Alfuzosin Hydrochloride, 81403-68-1, Uroxatral, Alfuzosin HCl, Xatral, Urion, Alfoten, Alfetim, Xatral Retard, Alfuzosin (hydrochloride), Xatral OD, Xatral SR, Xatral XL, Uroxatral (TN), Alfuzosin hydrochloride [USAN], SL 77499-10, SL 77 499-10, SL-7749910, Alfuzosin hydrochloride (Uroxatral), Alfuzosin hydrochloride (JAN/USAN), (+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride, SL-77499, SL-77499-10, SL-77.0499-10, DSSTox_CID_25514, DSSTox_RID_80924, DSSTox_GSID_45514, n-{3-[(4-amino-6,7-dimethoxychinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamidhydrochlorid, CHEBI:32286, 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)-, N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide hydrochloride, N-[3-[4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride, C19H27N5O4, N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide hydrochloride, N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl), SR-01000759345, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide hydrochloride, n-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride, Alfuzosin hydrochloride [USAN:USP], Uroxatral hydrochloride, Alfuzosin hydrochloride;, AC1L2GRP, AC1Q5PED, NCGC00016946-01, D0H1YQ, SL77.0499-10, CAS-81403-68-1, Alfuzosin Hydrochloride,(S), CHEMBL1723, C19H28ClN5O4, SCHEMBL179910, DTXSID3045514, CTK8F7637, HY-B0192A, MolPort-006-391-851, Uroxatral, Alfuzosin hydrochloride, YTNKWDJILNVLGX-UHFFFAOYSA-N, BCPP000417, HMS1569A05, 81403-80-7 (Parent), KS-00000XK8, Tox21_110701, Tox21_500224, MFCD00879135, s1409, (methyl)amino)propyl)tetrahydrofuran-2, AKOS015966770, Tox21_110701_1, AC-1116, API0001407, BCP9000271, CCG-213373, CS-2087, LP00224, NCGC00095152-09, NCGC00260909-01, AS-14240, AT-12271, BC677639, CC-23835, K448, LS-70107, AB0008072, AB2000094, A2591, FT-0630890, D01692, Alfuzosin hydrochloride, >=98% (HPLC), solid, 403A681, SR-01000759345-5, Alfuzosin hydrochloride, European Pharmacopoeia (EP) Reference Standard, Alfuzosin hydrochloride, United States Pharmacopeia (USP) Reference Standard, Alfuzosin for peak identification, European Pharmacopoeia (EP) Reference Standard, Alfuzosin for system suitability A, European Pharmacopoeia (EP) Reference Standard, Alfuzosin for system suitability, European Pharmacopoeia (EP) Reference Standard, Alfuzosin hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, 133880-44-1, 4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride, N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride, N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride, N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide hydrochloride, AKOS026749786